Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 2, 2013, Pages 215-221

  Miki, Yuichi ^a   Akimoto, Jiro ^b   Yokoyama, Sakino ^a   Homma, Tomomi ^a   Tsutsumi, Masateru ^b   Haraoka, Jo ^b   Hirano, Kazuya ^a   Beppu, Masatoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glioma; Necrosis; Photodynamic therapy; Talaporfin sodium

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; TALAPORFIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; CYTOCHROMES C; DNA FRAGMENTATION; GLIOMA; HUMANS; MITOCHONDRIA; NECROSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 84874054994     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00567     Document Type: Article

References (33)

1. Lacroix M, Abi-Said D, Fourney D.R., Gokaslan ZL, Shi W, DeMonte F, Lang F.F., McCutcheon IE, Hassenbusch SJ, Holland E, Hess K., Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg., 95, 190-198 (2001).
2. Namatame H, Akimoto J, Matsumura H., Haraoka J, Aizawa K. Photodynamic therapy of C6-implanted glioma cells in the rat brain employing second-generation photosensitizer talaporfin sodium. Photodiagn. Photodyn. Ther., 5, 198-209 (2008).
3. Sawaya R, Hammoud M, Schoppa D., Hess KR, Wu SZ, Shi WM, Wildrick DM Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery, 42, 1044-1055, discussion, 1055-1056 (1998).
4. Wilson CB. Glioblastoma: the past, the present, and the future. Clin. Neurosurg., 38, 32-48 (1992).
5. Perria C, Carai M, Falzoi A., Orunesu G, Rocca A, Massarelli G., Francaviglia N, Jori G. Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery, 23, 557-563 (1988).
6. Perria C, Capuzzo T, Cavagnaro G., Datti R, Francaviglia N, Rivano C., Tercero VE Fast attempts at the photodynamic treatment of human gliomas. J. Neurosurg. Sci., 24, 119-129 (1980).
7. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review. J. Photochem. Photobiol. B, 36, 157-168 (1996).
8. Dougherty TJ, Gomer CJ, Henderson B.W., Jori G., Kessel D, Korbelik M, Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst., 90, 889-905 (1998).
9. Dolmans DE, Fukumura D, Jain RK Photodynamic therapy for cancer. Nat. Rev. Cancer, 3, 380-387 (2003).
10. Agostinis P, Berg K, Cengel K.A., Foster TH, Girotti AW, Gollnick SO, Hahn S.M., Hamblin MR, Juzeniene A, Kessel D, Korbelik M., Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA Cancer J. Clin., 61, 250-281 (2011).
11. Lockshin RA, Zakeri Z. Caspase-independent cell death? Oncogene, 23, 2766-2773 (2004).
12. Budihardjo I, Oliver H, Lutter M., Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol., 15, 269-290 (1999).
13. Leist M, Nicotera P. The shape of cell death. Biochem. Biophys. Res. Commun., 236, 1-9 (1997).
14. Aizawa K, Okunaka T, Ohtani T., Kawabe H, Yasunaka Y, O'Hata S, Ohtomo N, Nishimiya K., Konaka C, Kato H, Hayata Y, Saito T. Localization of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues. Photochem. Photobiol., 46, 789-793 (1987).
15. Matsumura H, Akimoto J, Haraoka J., Aizawa K. Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma. Lasers Med. Sci., 23, 237-245 (2008).
16. Fietta P. Many ways to die: passive and active cell death styles. Riv Biol., 99, 69-83 (2006).
17. Maderna P, Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim. Biophys. Acta, 1639, 141-151 (2003).
18. Miki Y, Itoh T, Hirano K., Eda S, Hayashi A, Yamanaka M., Beppu M. Clearance of oxidatively damaged cells by macrophages: recognition of glycoprotein clusters by macrophage-surface nucleolin as early apoptotic cells. Biol. Pharm. Bull., 32, 564-572 (2009).
19. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta, 1776, 86-107 (2007).
20. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J. Immunol. Methods, 243, 167-190 (2000).
21. Di Stefano A., Ettorre A, Sbrana S., Giovani C, Neri P. Purpurin-18 in combination with light leads to apoptosis or necrosis in HL60 leukemia cells. Photochem. Photobiol., 73, 290-296 (2001).
22. Granville DJ, Carthy CM, Jiang H, Levy J.G., McManus BM, Matroule JY, Piette J, Hunt DW Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood, 95, 256-262 (2000).
23. Reiners JJ J.r., Caruso JA, Mathieu P, Chelladurai B., Yin XM, Kessel D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ., 9, 934-944 (2002).
24. Bellnier DA, Ho YK, Pandey R.K., Missert JR, Dougherty TJ Distribution and elimination of Photofrin II in mice. Photochem. Photobiol., 50, 221-228 (1989).
25. Kessel D, Whitcomb KL, Schulz V. Lipoprotein-mediated distribution of N-aspartyl chlorin-E6 in the mouse. Photochem. Photobiol., 56, 51-56 (1992).
26. Ferrario A, Kessel D, Gomer CJ Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 52, 2890-2893 (1992).
27. Gomer CJ, Ferrario A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 50, 3985-3990 (1990).
28. Kessel D. Interactions between N-aspartyl chlorin e6, detergent micelles and plasma lipoproteins. Photochem. Photobiol., 61, 646-649 (1995).
29. Kessel D. Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients. J. Photochem. Photobiol. B, 39, 81-83 (1997).
30. Robey RW, Steadman K, Polgar O., Bates SE ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy. Cancer Biol. Ther, 4, 187-194 (2005).
31. Liu L, Zhang Z, Xing D. Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage. Free Radic. Biol. Med., 51, 53-68 (2011).
32. Ogawa A, Wada T, Tedo T., Namiki T. Delayed radiation necrosis of the brain (author's transl.). Neurol. Med. Chir. (Tokyo), 19, 367-372 (1979).
33. Akimoto J, Haraoka J, Aizawa K. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. Photodiagn. Photodyn. Ther., 9, 91-99 (2012).